Zobrazeno 1 - 10
of 11
pro vyhledávání: '"J M van Woerkom"'
Autor:
N. J. Besselink, A. A. A. Westgeest, R. Klaasen, M. Gamala, J. M. van Woerkom, J. Tekstra, M. M. A. Verhoeven, W. E. Van Spil, F. P. J. G. Lafeber, A. C. A. Marijnissen, J. M. Van Laar, J. W. G. Jacobs
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background Assessment of disease activity is a critical component of tight-control, treat-to-target treatment strategies of rheumatoid arthritis (RA). Recently, the HandScan has been validated as a novel method for objectively assessing RA d
Externí odkaz:
https://doaj.org/article/7aeddec0d7b940cfa2f67aec32d6d6ac
Autor:
F.P.J.G. Lafeber, J M van Woerkom, Antonius A A Westgeest, Mihaela Gamala, Ruth Klaasen, Maxime M A Verhoeven, W.E. van Spil, A.C.A. Marijnissen, Janneke Tekstra, J.M. van Laar, J. W. G. Jacobs, Nicolle Besselink
Publikováno v:
Trials, 20(1). BioMed Central
Trials
Trials, Vol 20, Iss 1, Pp 1-10 (2019)
Trials
Trials, Vol 20, Iss 1, Pp 1-10 (2019)
Background Assessment of disease activity is a critical component of tight-control, treat-to-target treatment strategies of rheumatoid arthritis (RA). Recently, the HandScan has been validated as a novel method for objectively assessing RA disease ac
Autor:
W. de Jager, J.A. van Roon, Jwj Bijlsma, F.P.J.G. Lafeber, Aike A. Kruize, J. M. van Woerkom, A. Bikker, M. Wenting-van Wijk
Publikováno v:
Arthritis & Rheumatism. 62:969-977
Objective To study the expression levels and immunostimulatory capacities of interleukin-7 (IL-7) in primary Sjogren's syndrome. Methods Labial salivary gland (LSG) IL-7 expression was determined by immunohistochemistry, using a quantitative scoring
Autor:
E Knol, I C Bihari, J. W. J. Bijlsma, F.P.J.G. Lafeber, J M van Woerkom, Aike A. Kruize, M J G Wenting van Wijk, J. W. G. Jacobs, J.A. van Roon
Publikováno v:
Annals of the Rheumatic Diseases. 64:1474-1479
Objectives: To investigate whether differences in T helper (Th) 1 and Th2 cell activity in salivary glands ("local") or ("peripheral") blood can discriminate between Sjogren's syndrome (SS) and non-Sjogren's sicca syndrome (nSS-sicca). Additionally,
Autor:
Aike A. Kruize, E N van Roon, Suzanne M M Verstappen, J M van Woerkom, J. W. J. Bijlsma, J.A. van Roon, Rinie Geenen, R Goldschmeding
Publikováno v:
Annals of the rheumatic diseases. 66(8)
Background: For invalidating symptoms in primary Sjogren’s syndrome (pSS), there is still a need for easy-to-administer, cost-effective and well-tolerated systemic treatment. Leflunomide (LEF) is structurally unrelated to other immunomodulatory dru
Autor:
Hendrika Bootsma, J. W. G. Jacobs, PJ Barendregt, Louis Kater, Rjh Custers, J. M. van Woerkom, Aike A. Kruize, Jwj Bijlsma, R. J. Hene
Publikováno v:
Rheumatology, 45(4), 470-477. Oxford University Press
Objectives. Because patients with primary Sjogren's syndrome (pSS) are at risk of developing other autoimmune phenomena and malignant lymphoma, it is important to distinguish pSS from non-Sjogren's (nSS) sicca syndrome. However, this distinction migh
Publikováno v:
Clinical and experimental rheumatology. 22(3)
Autoantibodies to the ribonucleoproteins Ro/SS-A and La/SS-B are found in autoimmune diseases such as primary Sjögren's syndrome (pSS), systemic lupus erythematousus and rheumatoid arthritis. Increased and aberrant expression of Ro/SS-A and La/SS-B
Autor:
F E A, Udink ten Cate, J M P J, Breur, J M, van Woerkom, A A, Kruize, Ph, Stoutenbeek, E J, Meijboom
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 146(38)
Congenital complete atrioventricular block (CCAVB) is induced by the placental transmission of maternal anti-SS-A/Ro and anti-SS-B/La antibodies during the second trimester of pregnancy where they cause inflammatory injury to the foetal heart. Anti-S
Autor:
Marjonne C W Creemers, J M van Woerkom, T.H. Heurkens, O. F. C. van den Bosch, M. Custers, Nico M Wulffraat, M. Bulatovic Calasan
Publikováno v:
Annals of the Rheumatic Diseases. 71:655.3-655
Background Methotrexate (MTX)-related gastrointestinal adverse effects are very common during MTX treatment in patients with juvenile idiopathic arthritis (1). JIA patients also develop adverse effects occurring before MTX intake and when thinking of
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.